Chemcel Biotech
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Strengths
1- Stock is trading at 0.06 times its book value
Weaknesses
4- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -14.4% over past five years.
- Company might be capitalizing the interest cost
- Company has high debtors of 1,132 days.
Growth Rate
change over 1 year
change over 1 year
Quarterly Results
| Particulars | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 |
|---|---|---|---|---|
| Sales | 75.16 | 84.03 | 86.16 | 86.92 |
| Expenses | 70.87 | 73.74 | 74.97 | 79.84 |
| Operating Profit | 4.29 | 10.29 | 11.19 | 7.08 |
| OPM % | 5.71% | 12.25% | 12.99% | 8.15% |
| Other Income | -0.82 | 4.76 | 3.86 | 3.53 |
| Interest | 0.01 | 0 | 0.01 | 0 |
| Depreciation | 2.38 | 2.79 | 2.95 | 3.47 |
| PBT | 1.08 | 12.26 | 12.09 | 7.14 |
| Tax % | 41.67% | -3.1% | 0.08% | -0.42% |
| Net Profit | 0.63 | 12.64 | 12.08 | 7.18 |
| EPS (₹) | 0.49 | 9.8 | 9.36 | 5.57 |
Profit & Loss
| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2013 | Mar 2014 |
|---|---|---|---|---|---|---|---|---|
| Sales | 18.58 | 21.45 | 23.45 | 31.41 | 42.32 | 47.67 | 17.97 | 14.48 |
| Expenses | 17.15 | 19.18 | 20.55 | 28.36 | 39.39 | 45.2 | 19.18 | 14.81 |
| Operating Profit | 1.43 | 2.27 | 2.9 | 3.05 | 2.93 | 2.47 | -1.21 | -0.33 |
| OPM % | 7.7% | 10.58% | 12.37% | 9.71% | 6.92% | 5.18% | -6.73% | -2.28% |
| Other Income | 0.08 | 0.01 | 0 | 0 | 0 | 0 | 0.89 | 0 |
| Interest | 0.48 | 0.7 | 1.14 | 1.2 | 1.06 | 1.24 | 0 | 0 |
| Depreciation | 0.13 | 0.12 | 0.11 | 0.1 | 0.09 | 0.08 | 0.06 | 0.05 |
| PBT | 0.9 | 1.46 | 1.65 | 1.75 | 1.78 | 1.15 | -0.38 | -0.38 |
| Tax % | 22.22% | 35.62% | 25.45% | 25.14% | 23.03% | 24.35% | 0% | 0% |
| Net Profit | 0.7 | 0.94 | 1.23 | 1.31 | 1.37 | 0.87 | -0.37 | -0.38 |
| EPS (₹) | — | — | — | 0.51 | 0.53 | 0.31 | -0.13 | -0.14 |
| Div. Payout % | 95% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2013 | Mar 2014 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.65 | 10.52 | 10.52 | 25.92 | 25.92 | 27.92 | 27.92 | 27.92 |
| Reserves | 0.46 | 1.56 | 2.78 | 13.13 | 14.66 | 16.52 | 16.27 | 15.89 |
| Borrowings | 9.17 | 6.54 | 7.02 | 5.05 | 9.59 | 10.07 | 10.63 | 10.58 |
| Other Liabilities | 3.22 | 6.28 | 7.99 | 3.03 | 5.72 | 5.6 | 13 | 17.78 |
| Total Liabilities | 19.5 | 24.9 | 28.31 | 47.13 | 55.89 | 60.11 | 67.82 | 72.17 |
| Fixed Assets | 1.1 | 0.99 | 1.29 | 1.23 | 1.15 | 1.07 | 0.94 | 0.89 |
| CWIP | 5.8 | 0.13 | 0 | 7.37 | 7.37 | 7.37 | 7.37 | 7.37 |
| Investments | 0 | 0 | 0.03 | 0.03 | 0.03 | 0.03 | 0 | 0 |
| Other Assets | 12.6 | 23.78 | 26.99 | 38.5 | 47.34 | 51.64 | 59.51 | 63.91 |
| Total Assets | 19.5 | 24.9 | 28.31 | 47.13 | 55.89 | 60.11 | 67.82 | 72.17 |
Cash Flow
| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2013 | Mar 2014 |
|---|---|---|---|---|---|---|---|---|
| Operating | -5.68 | -6.48 | — | -14.08 | -4.98 | -3.76 | 0.08 | -0.13 |
| Investing | -5.79 | 5.65 | — | -8.67 | 0.25 | 0.25 | 0.03 | 0 |
| Financing | 11.45 | 0.84 | — | 22.68 | 4.69 | 3.48 | -0.1 | 0.19 |
| Net Cash Flow | -0.02 | 0.01 | — | -0.07 | -0.04 | -0.03 | 0.01 | 0.06 |
| Free Cash Flow | -11.48 | -0.83 | — | -21.48 | -4.98 | -3.76 | 0.08 | -0.13 |
| CFO/OP | -397 | -285 | — | -447 | -170 | -141 | -7 | 39 |
Ratios
| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2013 | Mar 2014 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 130 | 181 | 175 | 277 | 209 | 248 | 840 | 1,132 |
| Inventory Days | — | — | — | 46.8 | 48.17 | 45.53 | 80.07 | 102 |
| Days Payable | — | — | — | 14.76 | 31.5 | 12.2 | 183 | 366 |
| Cash Conversion Cycle | 130 | 181 | 175 | 309 | 226 | 281 | 737 | 868 |
| Working Capital Days | 183 | 297 | 293 | 397 | 350 | 347 | 856 | 1,063 |
| ROCE % | — | 12.38% | 14.33% | 9.16% | 6.03% | 4.57% | — | -0.7% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Chemcel Biotech insights
46 extracted metrics + investor summaries across FY06–FY15.
Documents
Frequently Asked Questions about Chemcel Biotech
What does Chemcel Biotech Ltd do?
Where is Chemcel Biotech Ltd (533026) listed?
Company Information
Chemcel Biotech Limited is an India-based company, which is a manufacturer of agro chemicals, such as insecticides, fungicides and plant growth promoters.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/533026.md for Chemcel Biotech Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.